Telehealth Ad Compliance — Google vs Meta

Telehealth ad compliance on Google vs Meta is not a comparison between strict and lenient — it is a comparison between two distinct systems with different architectures, different enforcement philosophies, and different strengths for different healthcare verticals. Understanding both well enough to run paid media effectively across both platforms is one of the defining competencies in telehealth marketing in 2026. Brands that treat them as interchangeable get burned on compliance; brands that understand the differences build more efficient, more defensible acquisition programs.

The short version: Google's compliance system is policy-based and documentation-heavy, with explicit certification requirements and transparent policy documentation. Meta's system is more judgment-based and enforcement-driven, with a pre-approval process for healthcare categories and an automated review system that produces less consistent outcomes. Both platforms require real compliance work; the work takes different forms.

Pre-Approval Requirements — Google vs Meta

Google's pre-approval requirements for healthcare advertising are explicit and structured. For telehealth brands that are advertising prescription drug access, online pharmacy services, or compounding pharmacy services, Google requires certification from an approved third-party verifier — LegitScript being the most widely used. This certification process happens before you can run ads in these categories. There is no workaround, and attempting to run these categories without certification results in systematic rejection.

Meta's pre-approval process for healthcare advertising is application-based and category-specific. Brands that want to advertise in restricted healthcare categories — which include pharmaceutical products, medical devices, and some health service categories — apply through Meta's healthcare advertiser authorization process. The application requires documentation of business legitimacy, licensing, and compliance program information. Once approved, the brand operates as an authorized healthcare advertiser with different permissions than standard advertisers.

The practical difference: Google's LegitScript requirement is more formal and takes longer to complete, but once certified, the path to running compliant ads is clearer. Meta's authorization process can be faster to initiate but produces less predictable outcomes — authorization for one healthcare category does not necessarily mean authorization for adjacent categories, and enforcement remains active even for authorized accounts.

Healthcare Policy Structures — How Each Platform Thinks About It

Google categorizes healthcare advertising with explicit sub-categories: prescription drugs (most restricted), non-prescription drugs and supplements, healthcare professionals and facilities, and clinical trial recruitment. Each category has documented requirements. For telehealth brands, knowing which category your service falls into determines exactly which rules apply, and the documentation tells you what those rules are specifically.

Meta's healthcare policy is broader and more interpretive. The framework restricts health and medical content that makes misleading claims, exploits health anxieties, or promotes restricted health products — but the specific application of these rules depends on how Meta's review systems interpret your particular ad. This produces more variability: the same ad may be approved one week and rejected the next as enforcement models update, or an ad that passes review in one account faces rejection in another.

The implication for strategy: Google rewards brands that do the documentation work upfront and run clearly within defined categories. Meta rewards brands that understand the patterns in how its enforcement systems actually behave and build creative that works within those patterns empirically rather than theoretically. Both approaches require real expertise; they are just different types of expertise.

Claim Restrictions in Practice

Both platforms prohibit disease cure claims and misleading health claims, but they enforce these restrictions differently. Google applies claim restrictions systematically and consistently — the policy documentation specifies what types of claims are prohibited, and ads containing those claim types fail review regardless of how the brand is positioned otherwise. "Cures diabetes" or "eliminates erectile dysfunction permanently" will fail Google review every time.

Meta's claim enforcement is more automated and context-dependent. The same language may pass review in one creative format and fail in another. Ads that combine health claims with certain visual elements — body transformation imagery, clinical settings, before/after formats — face higher claim scrutiny than ads where the same language appears without those visual signals. Understanding what visual-copy combinations trigger Meta's health claim flags is a real skill that separates effective healthcare advertisers from brands that constantly fight rejections.

Before/after content illustrates the platform differences clearly. Meta has an explicit restriction on idealized body image transformations in weight loss and health-related ads — the policy is focused on body image harm and applies to ads that show dramatic physical transformation in ways that could promote unhealthy body image. Google's restriction on before/after content is framed as a misrepresentation concern — the issue is whether the implied treatment outcome is accurate and substantiated, not the body image dimension specifically. Same content type, different policy rationale, different specific restrictions.

Prescription Drug Advertising — Where the Platforms Diverge Most

Prescription drug advertising is where Google and Meta diverge most significantly. Google explicitly prohibits prescription drug advertising without pre-authorization and has formal mechanisms for brands that qualify. The rules are clear, the enforcement is consistent, and unauthorized prescription drug ads fail reliably. If you want to run Google ads for prescription drug access, you do the certification work or you do not run those ads.

Meta restricts prescription drug advertising but enforces the restriction with more variability. Ads that are clearly pharmaceutical direct-to-consumer advertising fail review. Ads that are positioned as telehealth service access — consultation-forward framing that happens to result in prescription access — often pass review in categories like weight management, men's health, and hair loss where the consultation framing is established and accepted by Meta's review systems.

This variability is not a loophole — it reflects the genuine ambiguity in what constitutes "prescription drug advertising" versus "healthcare service advertising that leads to prescription treatment." Telehealth brands occupy that middle ground, and Meta's enforcement system acknowledges the ambiguity in ways that Google's more categorical system does not.

Account Trust, History, and Friction

Account trust and history matter significantly on Meta and much less on Google. A Meta ad account that has been active for years, has spent substantial amounts, has maintained a low policy violation rate, and has established healthcare advertiser authorization faces less friction than a new account or an account with a violation history. New ad accounts, especially in healthcare categories, face more scrutiny and rejection even for compliant campaigns — the system does not know you yet.

This Meta dynamic has meaningful strategic implications. Account health is a real asset that compounds over time. Protecting an established account by running conservative creative, avoiding borderline campaigns, and maintaining clean violation records is worth more than the marginal gain from testing aggressive creative that risks account flags. Brands that understand this protect their accounts as infrastructure rather than treating each ad rejection as a one-off problem.

Google's system is more policy-based and less account-history-driven. An ad that meets Google's policy requirements should pass review in a new account as reliably as in an established one, because compliance is determined by the ad and destination content meeting policy requirements, not by account standing signals. This makes Google more predictable for new entrants but less forgiving of policy mistakes — violations on Google are more likely to result in account-level restrictions than individual ad flags.

Which Platform for Which Telehealth Vertical

GLP-1 weight management programs perform well on Meta and are viable on Google with LegitScript certification. Meta's volume and targeting capabilities make it the primary acquisition channel for most GLP-1 telehealth brands; Google Search captures high-intent users who are past the awareness stage and actively seeking a provider. Running both is the standard approach for brands at scale.

TRT and men's hormone health work on Meta with service framing and established account history. Google is viable for consultation-focused campaigns. YouTube (within Google's ecosystem) adds educational format video that performs well for TRT awareness campaigns targeting men researching hormone health.

ED treatment runs primarily on Meta, where the policy environment for telehealth consultation framing is more established than on Google. Google Search for ED is viable but competitive and expensive. YouTube for ED requires genuinely educational creative and is more viable for awareness than direct conversion.

Peptide and compounded medication telehealth runs most reliably on Meta with service framing and on Google Search with LegitScript certification. Both platforms require careful landing page management to keep compound-specific content out of the paid advertising funnel.

Hair loss treatment and female Rx categories (including birth control, hormonal health, and similar) have relatively workable paths on both Meta and Google — these categories have established telehealth advertising precedent and less aggressive enforcement than GLP-1 or ED categories.

Running Both Simultaneously

Most successful telehealth brands at meaningful scale run Meta and Google as complementary channels rather than choosing between them. The channels serve different moments in the patient acquisition journey. Meta drives awareness and initial consideration — its targeting capabilities surface relevant audiences who were not actively searching, and its creative formats build the emotional and informational case for acting. Google Search captures intent-driven users who are already in research or comparison mode and are closer to conversion.

The compliance overhead for running both simultaneously is real: you are maintaining two distinct policy environments, two sets of creative requirements, and two approval processes. Brands that try to run identical creative across both platforms find that what works on Meta often needs adjustment for Google, and vice versa. Building platform-specific creative and maintaining platform-specific compliance awareness is the cost of using both channels effectively — and for most telehealth verticals, that cost is well justified by the combined patient acquisition capacity.